XTB

N-[(3-chloro-4-cyanophenyl)methyl]-N-methyl-2-[6-{1-[(2R)-oxetane-2-carbonyl]piperidin-4-yl}-4-oxoquinazolin-3(4H)-yl]acetamide

Created:	2023-06-08
Last modified:	2024-12-18

Find Related PDB Entry
1 entries where XTB is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	1
Bond Count	70
Aromatic Bond Count	12

2D diagram of XTB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(3-chloro-4-cyanophenyl)methyl]-N-methyl-2-[6-{1-[(2R)-oxetane-2-carbonyl]piperidin-4-yl}-4-oxoquinazolin-3(4H)-yl]acetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(3-chloranyl-4-cyano-phenyl)methyl]-~{N}-methyl-2-[6-[1-[(2~{S})-oxetan-2-yl]carbonylpiperidin-4-yl]-4-oxidanylidene-quinazolin-3-yl]ethanamide
Formula	C₂₈ H₂₈ Cl N₅ O₄
Molecular Weight	534.006
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N1CCC(CC1)c1ccc2N=CN(CC(=O)N(C)Cc3ccc(C#N)c(Cl)c3)C(=O)c2c1)C1CCO1
SMILES	CACTVS	3.385	CN(Cc1ccc(C#N)c(Cl)c1)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)[CH]5CCO5
SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)C5CCO5
Canonical SMILES	CACTVS	3.385	CN(Cc1ccc(C#N)c(Cl)c1)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)[C@@H]5CCO5
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(Cc1ccc(c(c1)Cl)C#N)C(=O)CN2C=Nc3ccc(cc3C2=O)C4CCN(CC4)C(=O)[C@@H]5CCO5
InChI	InChI	1.06	InChI=1S/C28H28ClN5O4/c1-32(15-18-2-3-21(14-30)23(29)12-18)26(35)16-34-17-31-24-5-4-20(13-22(24)27(34)36)19-6-9-33(10-7-19)28(37)25-8-11-38-25/h2-5,12-13,17,19,25H,6-11,15-16H2,1H3
InChIKey	InChI	1.06	XIFPUYLQCKLVLP-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	172635981

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.